MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0000983
Chemecca Labs Private Limited
Chemecca Labs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹5.65 Cr
Latest filing
Net profit · FY 2022
₹13.63 Lakh
Net margin 2.4%
EBITDA · FY 2022
-₹18.23 Lakh
EBITDA margin -3.2%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Chemecca Labs Private Limited
Data last updated:
Chemecca Labs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC356601. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Rohit Sethi and Aadesh Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1332 2nd Floor Mahatta Chambers, D B Gupta Road Karol Bagh, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.65 Cr. For the same year it recorded a net profit of ₹13.63 Lakh (net margin 2.4%) and EBITDA of -₹18.23 Lakh (EBITDA margin -3.2%).
Chemecca Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0000983).
Company details
CIN U24230DL2019PTC356601
Registration Number 356601
Incorporation Date 24 October 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0000983
Recognitions & Rankings of Chemecca Labs
Contact details
Chemecca Labs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1332 2nd Floor Mahatta Chambers, D B Gupta Road Karol Bagh, New Delhi, Delhi, India – 110005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Chemecca Labs Private Limited, buy the company report.
Comprehensive company report
Chemecca Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Chemecca Labs Private Limited
FY 2025 filings availableChemecca Labs Private Limited reported revenue of ₹5.65 Cr for FY 2022.
Revenue · FY 2022
₹5.65 Cr
Net profit · FY 2022
₹13.63 Lakh margin 2.4%
EBITDA · FY 2022
-₹18.23 Lakh margin -3.2%
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹5.65 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹18.23 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹13.63 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -3.2% | ||
| Net Profit Margin | 2.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Chemecca Labs Private Limited, buy the company report.
Board of directors of Chemecca Labs Private Limited
Chemecca Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aadesh Bhandari | Additional Director | 09 Dec 2023 | 2 Years 10 Months | Current |
| Rohit Sethi | Director | 24 Oct 2019 | 7 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Chemecca Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chemecca Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Chemecca Labs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Chemecca Labs Private Limited, buy the company report.
Recent activity
Chemecca Labs Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Aadesh Bhandari was appointed as Additional Director on 09 Dec 2023.
AGM
Chemecca Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chemecca Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Aadesh Bhandari was appointed as Additional Director.
Ceased
Aditi Jain ceased to be Director.
Appointed
Rohit Sethi was appointed as Director.
Incorporation
24 Oct 2019
Chemecca Labs Private Limited was registered on 24 Oct 2019 with Roc Delhi Ii & aged 7 years 5 days as per MCA records.
Frequently asked questions
Chemecca Labs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 October 2019 (7+ years old) and is registered under CIN U24230DL2019PTC356601.
Chemecca Labs has 2 current directors:
- Aadesh Bhandari - Additional Director
- Rohit Sethi - Director
The latest financial statements of Chemecca Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
No. Chemecca Labs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Chemecca Labs is U24230DL2019PTC356601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemecca Labs was incorporated on 24 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Aadesh Bhandari was appointed as Additional Director on 09 Dec 2023. Aditi Jain ceased to be Director on 09 Dec 2023. Rohit Sethi was appointed as Director on 24 Oct 2019.
Yes, Chemecca Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0000983).
The registered office of Chemecca Labs is at 1332 2nd Floor Mahatta Chambers, D B Gupta Road Karol Bagh, New Delhi, Delhi, India – 110005.
Chemecca Labs operates in the pharma industry, in the drug formulation and development segment.